Literature DB >> 25679113

Proinflammatory cytokine responses in patients with psoriasis.

Anargyros Kouris1, Aikaterini Pistiki2, Alexandros Katoulis1, Marianna Georgitsi2, Sofia Giatrakou1, Evangelia Papadavid1, Mihai G Netea3, Nikolaos Stavrianeas1, Evangelos J Giamarellos-Bourboulis4.   

Abstract

BACKGROUND: Psoriasis is one of the most common, immune-mediated, chronic inflammatory skin diseases. Proinflammatory cytokines play an important pathogenetic role at a local level.
OBJECTIVE: To assess whether the proinflammatory cytokines IL-1β, IL-6, IL-17, IL-22 and TNF-α are released systemically during psoriasis.
METHODS: Peripheral blood mononuclear cells (PBMCs) were isolated from 30 patients with psoriasis and 30 healthy volunteers. Cytokine production was assessed in supernatants using an enzyme immunoassay after stimulation of PBMCs with microbial stimuli. In addition, flow cytometry was used to determine the subsets of monocytes involved and the intracellular TNF-α production in monocytes.
RESULTS: IL-17 levels were significantly higher in the supernatants of PBMCs from psoriatic patients after stimulation with phytohemagglutinin. TNF-α production was also significantly higher in cells from psoriatic patients after stimulation with all stimuli, as compared with health volunteers. Similar changes were not found for the other cytokines. A statistically significant difference was observed between patients and controls for inflammatory CD14(+)/CD16(+) monocytes (p<0.0001) and patrolling CD14-/CD16(+) monocytes.
CONCLUSION: Hyper-production of TNF-α is documented in psoriasis. These results support the concept that there is a systemic, proinflammatory component in psoriasis.

Entities:  

Keywords:  IL-17; IL-1β; IL-22; IL-6; TNF-α; monocytes; psoriasis

Mesh:

Substances:

Year:  2014        PMID: 25679113     DOI: 10.1684/ecn.2014.0358

Source DB:  PubMed          Journal:  Eur Cytokine Netw        ISSN: 1148-5493            Impact factor:   2.737


  11 in total

1.  Role of podoplanin in the high interleukin-17A secretion resulting from interactions between activated lymphocytes and psoriatic skin-derived mesenchymal cells.

Authors:  M Noack; N'd Ndongo-Thiam; P Miossec
Journal:  Clin Exp Immunol       Date:  2016-08-09       Impact factor: 4.330

Review 2.  Psoriasis, non-alcoholic fatty liver disease, and cardiovascular disease: Three different diseases on a unique background.

Authors:  Giulia Ganzetti; Anna Campanati; Elisa Molinelli; Annamaria Offidani
Journal:  World J Cardiol       Date:  2016-02-26

3.  Monoclonal antibody against macrophage colony-stimulating factor suppresses circulating monocytes and tissue macrophage function but does not alter cell infiltration/activation in cutaneous lesions or clinical outcomes in patients with cutaneous lupus erythematosus.

Authors:  K Masek-Hammerman; E Peeva; A Ahmad; S Menon; M Afsharvand; R Peng Qu; J B Cheng; J Syed; Y Zhan; S P O'Neil; S Pleasic-Williams; L A Cox; D Beidler
Journal:  Clin Exp Immunol       Date:  2015-11-09       Impact factor: 4.330

4.  Therapeutic Effects of Erythroid Differentiation Regulator 1 on Imiquimod-Induced Psoriasis-Like Skin Inflammation.

Authors:  Kyung Eun Kim; Younkyung Houh; Hyun Jeong Park; Daeho Cho
Journal:  Int J Mol Sci       Date:  2016-02-17       Impact factor: 5.923

5.  Correlation between IL36α and IL17 and Activity of the Disease in Selected Autoimmune Blistering Diseases.

Authors:  Agnieszka Żebrowska; Anna Woźniacka; Katarzyna Juczyńska; Kamila Ociepa; Elżbieta Waszczykowska; Izabela Szymczak; Rafał Pawliczak
Journal:  Mediators Inflamm       Date:  2017-05-10       Impact factor: 4.711

6.  Subsets of activated monocytes and markers of inflammation in incipient and progressed multiple sclerosis.

Authors:  Mikkel Carstensen Gjelstrup; Morten Stilund; Thor Petersen; Holger Jon Møller; Eva Lykke Petersen; Tove Christensen
Journal:  Immunol Cell Biol       Date:  2017-12-11       Impact factor: 5.126

7.  Elevated Gene Expression of Interleukin-32 Isoforms Alpha, Beta, Gamma, and Delta in the Peripheral Blood of Chronic Psoriatic Patients.

Authors:  Hani A Al-Shobaili; Zafar Rasheed
Journal:  Diseases       Date:  2018-03-14

8.  Activated monocytes and markers of inflammation in newly diagnosed multiple sclerosis.

Authors:  Mikkel Carstensen; Tove Christensen; Morten Stilund; Holger J Møller; Eva L Petersen; Thor Petersen
Journal:  Immunol Cell Biol       Date:  2020-05-05       Impact factor: 5.126

9.  Individual responsiveness of macrophage migration inhibitory factor predicts long-term cognitive impairment after bacterial meningitis.

Authors:  Anne T Kloek; Mercedes Valls Seron; Ben Schmand; Michael W T Tanck; Arie van der Ende; Matthijs C Brouwer; Diederik van de Beek
Journal:  Acta Neuropathol Commun       Date:  2021-01-06       Impact factor: 7.801

10.  Serum interleukin-30 level in patients with psoriasis and its correlation with psoriasis severity: a case-control study.

Authors:  Nergez Sabah Omar; Xinxin Long; Jiayi Xian; Henok Kessete Afewerky; Saeed Ghulam Hussain; Xuebiao Peng
Journal:  J Int Med Res       Date:  2021-04       Impact factor: 1.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.